Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Bioactive and Compatible Polymers
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Haratake, M.
Right arrow Articles by Ottenbrite, R. M.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Oligopeptides as an Oral Delivery System: I. Aggregation Characteristics and Drug Encapsulation

Mamoru Haratake

Department of Chemistry, Virginia Commonwealth University, 1001 West Main St., Richmond, VA 23284-2006

Raphael M. Ottenbrite

Department of Chemistry, Virginia Commonwealth University, 1001 West Main St., Richmond, VA 23284-2006

A series of glutamic acid(E)-phenylalanine(F) oligopeptides were studied as potential oral drug delivery systems for protein and polysaccharide drugs. The aggregation behavior of the tri- and tetrapeptides (pEE(a)F, pEE(y)F, pEE(a)F(y)F) were characterized by light scattering and light microscopy. The tripeptides did not form aggregates up to 0.1 M at pH 2. On the other hand, the tetrapeptide pEE(a)F(y)F formed self-aggregates at relatively low concentrations (11.8 mM). This tetrapeptide also associated preferentially with several drug molecules, such as insulin and bovine serum albumin, below the concentration at which the aggregation occurred. The same concentration of unassociated pEE(a)F(y)F was necessary to achieve aggregation whether the pEE(a)F(y)F was associated with drugs or not. The pEE(a)F(y)F also formed unique spheres in the presence of protein drugs.

Journal of Bioactive and Compatible Polymers, Vol. 12, No. 2, 112-126 (1997)
DOI: 10.1177/088391159701200203


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?